regulatory approvals

Biotech

Agenus withdraws cervical cancer application for balstilimab

Agenus is withdrawing an application for a cervical cancer drug after the FDA granted full approval to Merck’s Keytruda in the same indication.
Annalee Armstrong Oct 22, 2021 8:00am

FDA stands by Aduhelm approval, use of accelerated pathway

Jul 13, 2021 3:33pm

Boston Scientific’s radioactive implant extends cancer survival

Mar 29, 2021 11:58am

Fauci: FDA will make its own decisions about COVID-19 vaccines

Aug 7, 2020 5:15am

BIO explores COVID-19's opportunities for big data, new regs

Jun 10, 2020 9:10am

FDA goes against AdComm votes 22% of the time, study finds

Jul 17, 2019 8:50am